Image
Explore the key conclusions around aiming for higher treatment targets, discussed at the UCB-sponsored Satellite Symposium presented at EULAR 2023.
Our resources section is designed to be a toolkit supporting every step of your healthcare journey.
Infographic2 minutes read
PsA and axSpA have overlapping disease manifestations which are driven by inflammation.1 Explore several extracellular cytokines that are implicated in these...
EU-DA-2400655
Video2 minutes watch
Watch Prof Frank Behrens discuss the importance of treating skin symptoms in addition to musculoskeletal symptoms for patients with SpA.
EU-DA-2400671
Video3 minutes watch
Achieving ACR50 is associated with improvements in quality of life for patients with PsA.1 Dive into the data supporting higher treatment targets in clinical...
EU-DA-2400650
Video3 minutes watch
Watch Prof Lars Erik Kristensen and Prof Frank Behrens discuss how MDA is a realistic treatment target in clinical practice and the barriers to achieving it for...
EU-DA-2400669
Video2 minutes watch
Treatment for PsA should target a broad range of musculoskeletal and extra-articular manifestations.1 Listen to Assoc. Prof Philipp Sewerin explain how MDA can...
EU-DA-2400668
EU-DA-2300319
Date of preparation: November 2023